STM2457 靶向 METTL3 的抗肿瘤作用机制及临床应用进展
吕欣慧 , 王佳琳 , 王喆 , 梁珊珊 , 王若雨
大连医科大学学报 ›› 2026, Vol. 48 ›› Issue (3) : 245 -251.
STM2457 靶向 METTL3 的抗肿瘤作用机制及临床应用进展
METTL3 inhibitor STM2457: antitumor mechanisms and clinical application progress
N6-甲基腺苷(m6A)甲基化修饰作为 RNA 层面的关键表观遗传调控方式,在肿瘤的发生、进展、侵袭及免疫逃逸过程中具有重要作用。甲基转移酶样蛋白 3(METTL3)是 m6A 甲基转移复合物的核心催化亚基,其异常激活被认为是多种恶性肿瘤发生的驱动因素。近年来,随着高选择性小分子抑制剂 STM2457 及临床候选药物 STC-15 的研发,靶向 METTL3 的抗肿瘤研究实现了从基础机制探索到临床转化的突破。本综述系统总结了 STM2457 的药物结构、作用机制、联合治疗策略及临床试验研究进展。
N6-methyladenosine (m6A) methylation modification is a crucial epigenetic regulatory mechanism at the RNA level, playing an important role in tumorigenesis, progression, and immune evasion. Methyltransferase-like protein 3 (METTL3) is the core catalytic subunit of the m6A methyltransferase complex, and its aberrant activation is considered a driving factor in the development of various malignant tumors. In recent years, with the development of highly selective inhibitors such as STM2457 and the clinical candidate drug STC-15, antitumor research targeting METTL3 has achieved breakthrough from basic mechanism exploration to clinical translation. This review comprehensively elaborates on the molecular structure, functional mechanism, combination therapy regimens, and clinical trial progress of the METTL3 inhibitor STM2457.
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
Barbieri I, Tzelepis K, Pandolfini L, |
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
Wang W, Shao F, |
| [13] |
王安祺. METTL3 调控 SRPK1 的 m6A 甲基化修饰介导有氧糖酵解促进肺腺癌细胞增殖的机制研究[D]. 苏州: 苏州大学, 2023. |
| [14] |
|
| [15] |
|
| [16] |
庄家敏, 赵培培, 杨媛媛, |
| [17] |
Yi Y, Fry J, Yum C, |
| [18] |
高川力, 周锡, 邹江, |
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
刘博琛. ZBTB7A m6A 修饰在结直肠癌肝转移中作用及机制研究[D]. 济南: 山东大学, 2024. |
| [24] |
|
| [25] |
|
| [26] |
吴荣寿. METTL3 介导 RNA 甲基化修饰调控 PD-L1 表达促进肝癌免疫逃逸的机制研究[D]. 南昌: 南昌大学, 2024. |
| [27] |
|
| [28] |
李敏. Mettl3/Ythdf2 介导的 Egr1m6A 修饰在调控结直肠癌单核样髓源性抑制细胞分化中的作用机制研究[D]. 镇江: 江苏大学, 2024. |
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
柏睿. APC 突变通过 METTL3-VISTA 信号轴介导结直肠癌免疫逃逸的机制研究[D]. 广州: 南方医科大学, 2024. |
| [35] |
赵荣. 靶向 METTL3 在 NSCLC 中增强免疫抑制剂抗肿瘤效应的机制研究[D]. 武汉: 华中科技大学, 2024. |
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
Brewer G. METTL3 inhibition enhances anti-tumour immunity[J]. Nat Rev Cancer, 2023, 23(10): 654. DOI: 10.1038/s41568-023-00621-2. |
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
国家自然科学基金项目(82172822)
辽宁省国际科技合作项目(2024JH2/101900006)
辽宁省科学技术计划-联合计划-关键技术攻关项目(2024JH2/102600067)
大连大学交叉学科发展项目(DLUXK-2025-FX-001)
/
| 〈 |
|
〉 |